Results 101 to 110 of about 71,955 (233)

Epistaxis Rates and Health Care Utilization in Patients With a Ventricular Assist Device

OTO Open
Objective Identify baseline epistaxis rates and epistaxis‐related health care utilization trends in the ventricular assist device (VAD) population.
Eric Rohe, Sarah Schmoker, Kaeli Samson, Kristy Carlson, Jayme Dowdall   +4 more
doaj   +1 more source

Gender matter in isotretinoin therapy for acne vulgaris? A retrospective study [PDF]

, 2015
Introduction: Gender differences have been recently highlighted for several aspects of acne vulgaris such as epidemiology, pathogenesis, clinical course, quality of life and treatment outcome.
Balduzzi, Veronica, Bernardini, Nicoletta, LA VIOLA, Giorgio, Pampena, Riccardo, Potenza, Concetta, Proietti, Ilaria, Rasras, Fowzieh, Skroza, Nevena, Tolino, Ersilia, Zuber, Sara   +9 more
core   +1 more source

Epistaxis in Adults: Management and Outcome

The Iraqi Journal of Medical Sciences
Background: Epistaxis is defined as bleeding from the nose. It is the most common emergency encountered by otolaryngologists. It affects all age groups and both genders. Several different modalities can be used to control nose bleeds.
Saif Saeed, Jaafar Kadhim
doaj   +1 more source

Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis

Otolaryngology Head & Neck Surgery, 2018
Objectives The aim of this study (PROSPERO ID: CRD42017081952) was to evaluate medical treatment for epistaxis from hereditary hemorrhagic telangiectasia (HHT).
Yuan-Pin Hsu, Chin-Wang Hsu, C. Bai, Sheng-Wei Cheng, Chiehfeng Chen   +4 more
semanticscholar   +1 more source

Knowledge and practices of epistaxis in Eastern Tanzania: A cross-sectional study of an emergency in otorhinolaryngology

African Journal of Emergency Medicine
Introduction: It's approximated that 60% of the population globally experience epistaxis during lifetime. Despite epistaxis being prevalent in Tanzania, there are limited studies that have explored experience of participants on epistaxis. This study aims
Zephania Saitabau Abraham, Onesmo Cyprian Fussi, Aveline Aloyce Kahinga   +2 more
doaj  

Case Report: Massive epistaxis from juvenile angiofibroma in an adolescent with severe haemophilia A [version 1; peer review: 3 approved]

F1000Research, 2019
Epistaxis may be profuse in individuals with normal bleeding parameters, but in an individual with haemophilia, it may be life-threatening. It is even more dangerous when epistaxis is caused by an undetected concomitant juvenile angiofibroma, and only ...
Jose Florencio F. Lapeña, Olivia Agnes D. Mejia   +1 more
doaj   +1 more source

NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. [PDF]

, 2015
BACKGROUND: The current study was conducted to assess acute and late adverse events (AEs), overall survival (OS), pelvic failure, regional failure, distant failure, and disease-free survival in a prospective phase 2 clinical trial of bevacizumab and ...
Bosch, Walter R., Erickson, Beth A., Gaffney, David K., Horowitz, Neil S., Jhingran, Anuja, Mannel, Robert S S., Matulonis, Ursula A., Miller, Brigitte E., Moughan, Jennifer, Portelance, Lorraine, Small, William, Souhami, Luis, Viswanathan, Akila N., Winter, Kathryn A., Xiao, Ying   +14 more
core   +2 more sources

Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets. [PDF]

, 2014
BackgroundPulmonary first pass filtration of particles marginally exceeding ∼7 µm (the size of a red blood cell) is used routinely in diagnostics, and allows cellular aggregates forming or entering the circulation in the preceding cardiac cycle to lodge ...
AD Kjeldsen, AD Kjeldsen, AE Guttmacher, AJ Easey, B Barzilai, B Nieswandt, Basel Chamali, BD Butler, BJ Folz, BM Silva, C Coupland, C Shovlin, CJ Gallione, CL Shovlin, CL Shovlin, CL Shovlin, CL Shovlin, CL Shovlin, CL Shovlin, CL Shovlin, CL Shovlin, Claire L. Shovlin, DW Johnson, E Buscarini, ER Chilvers, ER Weibel, F Roked, Gillian Angus, H Finnamore, Hannah C. Tighe, HL Devlin, IS Anand, J Feinstein, J Parra, J Remy, JA Dutton, JA Feinstein, JA Livesey, James E. Jackson, JE Van de Pette, JJ Mager, JL Hart, John A. Livesey, John Meek, K Clark, K Hara, K Nanthakumar, K Ono, K Zukotynski, KL Furie, Klaus Brusgaard, LC Weng, LS Valberg, M Bajc, M Billinger, M Blomley, M Moussouttas, M Nakayama, M Yeung, ME Faughnan, Michael A. Laffan, MK Whyte, MW van Gent, MW van Gent, OS AAssar, P Gazzaniga, P Gupta, P Shovlin CL, Wilmshurst, PC Hébert, RD Thompson, RF Gillum, Richard Manning, S Jackson, S Uchiyama, S Velthuis, SM Bang, T Krings, T Ueki, V Cottin, Vatshalan Santhirapala, WB Porter, Y Benjamini, Y Shinohara, Z Hao   +83 more
core   +3 more sources

Combined Factor VII and X Deficiency [PDF]

, 2011
Factor VII deficiency and factor X deficiency and very rare disorders individually. Combined Factor VII and X is a rare congenital blood disorder with very few cases reported in the literature.
Arora, Sunita, Narang, Gursharan Singh, Pahwa, Jivtesh Singh   +2 more
core  

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)

Journal of Otolaryngology - Head & Neck Surgery, 2019
BackgroundEpistaxis is the most common symptom of hereditary hemorrhagic telangiectasia (HHT), affecting more than 98% of adults with HHT, with significant impact on quality of life.
John M. Lee, Vincent Wu, M. Faughnan, A. Lasso, A. Figol, S. Kilty   +5 more
semanticscholar   +1 more source